肌瘤在癌症新陈代谢中的作用
Alec C Kimmelman1,2, Mara H Sherman3
1Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, New York 10016, USA shermam1@mskcc.org alec.kimmelman@nyulangone.org.
Cold Spring Harbor perspectives in medicine
|September 11, 2023
概括
癌细胞为生长重编程新陈代谢,利用通过自和巨细胞细胞分裂的营养物质. 向瘤代谢,包括 stromal 相互作用,提供潜在的癌症疗法.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 代谢途径 代谢途径
背景情况:
- 改变瘤细胞代谢是癌症的标志,受遗传突变,组织起源和瘤微环境的影响.
- 代谢变化为癌细胞提供能量和增殖的基石.
- 瘤表现出新陈代谢可塑性,通过自和巨细胞细胞分解吸收营养,并与树皮细胞形成网络.
研究的目的:
- 审查瘤代谢在癌症进展中的关键作用.
- 阐明瘤微环境的贡献,特别是 stromal 细胞,通过代谢相互作用支持瘤生长.
- 突出治疗瘤代谢的挑战和潜力.
主要方法:
- 文献综述侧重于癌症代谢和瘤微环境相互作用.
- 分析癌细胞改变新陈代谢的机制.
- 检查瘤微环境中的营养清除途径 (自,巨细胞) 和代谢共生.
主要成果:
- 瘤代谢被重新编程以支持快速增殖和生存.
- 瘤的微环境,特别是 stromal 细胞,积极参与瘤生长的代谢支持.
- 代谢可塑性和细胞间代谢网络带来治疗挑战,但也带来了机遇.
结论:
- 了解瘤新陈代谢及其与肌膜的相互作用对于开发有效的癌症疗法至关重要.
- 准代谢漏洞,包括 stromal 贡献,是一个有前途的治疗策略.
- 进一步研究瘤微环境中的代谢相互作用是有必要的.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
Electron Transport Chain: Complex I and II
14.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.4K


